ESPAUR Report 2020-21 Webinar

19 November 2021, Online

 

The United Kingdom Health Security Agency (UKHSA) held a webinar summarising the key findings from the English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2020 to 2021.

The recording from the webinar that took place on Friday 19 November is available below. Data presented is from 1 April 2020 to 31 March 2021 unless otherwise specified. Methods are not presented, for full details please refer to the ESPAUR Report.

Agenda

Chair: Dr Diane Ashiru-Oredope

Welcome
Introduction from Dr Susan Hopkins
Part 1: Chapters 2 to 6

Antibiotic Resistance – Jamie Rudman

Acquired Carbapenemase-Producing Gram-Negative Bacteria – Kirsty Bennet

Antifungal Resistance, Prescribing and Stewardship – Holly Fountain

Antibiotic consumption – Sabine Bou-Antoun

Antimicrobial Stewardship – Diane Ashiru-Oredope

Part 1 Q & A
Part 2: Chapters 7 to 11

NHS England and NHS Improvement: improvement and assurance schemes – Elizabeth Beech

Professional Education, Training and Public Engagement – Catherine Hayes

Keep Antibiotics Working Evaluation – Ella Sunyer

Research – Julie Robotham

Stakeholder Engagement – Ella Casale, Diane Ashiru-Oredope

Part 2 Q & A
Closing remarks

 

 

 

Recording

ESPAUR Report Webinar Part 1

 

ESPAUR Report Webinar Part 2

 

 

Feedback

Thank you for watching, we would be very grateful for your feedback. Please complete the feedback questionnaires below:

 

Acknowledgements

Chapter 1. Introduction Susan Hopkins

Chapter 2. Antibiotic resistance Emma Carter, Jamie Rudman, David Canitrot, Daniel Bradshaw, Martin Dedicoat, Rosanne DeJong, GRASP team, Angie Lackenby, Tamyo Mbisa, Rachel Merrick, Respiratory Virus Unit, Tuberculosis Unit, Kate Wilson, Colin Brown, Sarah Gerver. Rebecca Guy

Chapter 3. Acquired carbapenemase-producing Gram-negative bacteria Rebecca Guy, Kirsty Bennet, Katie Hopkins, Katherine Henderson, Gauri Godbole, Alice Ledda, Diane Pople, Colin Brown, Sarah Gerver

Chapter 4. Antifungal resistance, prescribing and stewardship Holly Fountain, Andy Borman, Colin Brown, Elizabeth Johnson, Mark Leach, Malcolm Qualie, Riina Rautema-Richardson, Sarah Gerver, Rebecca Guy

Chapter 5. Antibiotic consumption Sabine Bou-Antoun, Angela Falola, Holly Fountain, Hanna Squire, Emma Budd, Colin Brown, Susan Hopkins, Sarah Gerver

Chapter 6. Antimicrobial stewardship Donna Lecky, Elizabeth Beech, Ella Casale, Emily Cooper, Shawon Gonzales, Catherine Hayes, Eirwen Sides, Amy Thomas, Diane Ashiru-Oredope.

Chapter 7. NHS improvement and assurance schemes Elizabeth Beech, Emma Budd, Audrey Opoku, Hanna Squire.

Chapter 8. Professional education and training and public engagement Donna Lecky, Rosie Allison, Catherine Hayes, Wendy Thompson, Mohamad Sadak, Magda Hann, Gina Chen, Emily Cooper, Kirn Chakraborty, Angela Baker, Jordan Charlesworth, Aoife Hendrick, Shawon Gonzales, Elizabeth Ward, Vincent Ng, Graham McKenzie, Diane Ashiru-Oredope.

Chapter 9. Keep antibiotics working evaluation Alison A Hardy.

Chapter 10. Research Emily Agnew, Gisela Robles Aguilar, Haroon Ahmed, Juliet Allibone, Rosie Allison, Michelle Cole, Simon Collin, Emily Cooper, Stephanie Evans, Natalie Gold, Aleksandra Herbec, Alison Holmes, Donna Lecky, Alice Ledda, Monsey McLeod, Cliodna McNulty, Ginny Moore, Nichola Naylor, Diane Pople, Brieze Read, Leigh Sanyaolu, Eirwen Sides, Mark Sutton, Amy Thomas, Sarah Tonkin-Crine, Sarah A Walker, Catherine Wloch, Julie Robotham.

Chapter 11. Stakeholder engagement Diane Ashiru-Oredope, Christian Binns, Naomi Bull, Ella Casale, Michael Corley, Mary Collier, Tamsin Dewe, Jeff Featherstone, Rose Gallagher, Shawon Gonzales, Kieran Hand, Kitty Healey, Martin Llewelyn, William Malcolm, Sannah Malik, Angela McFarlane, Nicholas Reid, Tracy Rogers, Helena Rosado, Mohamed Sadak, Muhammad Sartaj, Jonathan Underhill, Jamie Woodward.

Further acknowledgements ESPAUR Oversight Group, Professor Alan Johnson, Diane Ashiru-Oredope, Ella Casale and Shawon Gonzales. Infographics by Jon White.

We would like to thank the ESPAUR Oversight Group and all its stakeholders for their help in reviewing the report and their continued support of the ESPAUR programme.